Obermatt
See Similar Stocks →

Tiziana Life Sciences

NAQ:TLSA · BMG889121031
BiotechnologyX-Small

360° View

67
Price/Sales—
Price/Earnings69
Price/Book87
Dividend Yield1
Revenue Growth—
Profit Growth51
Capital Growth61
TSR 52w33
Leverage17
Liquidity7
Refinancing23
Combined47
Analyst Opinions100
Pro Holdings15
Opinion Changes50
Market Pulse65

Profile

CountryUK
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Employees7
Websitetizianalifesciences.com
ISINBMG889121031
Last UpdateApr 2, 2026
Index & Theme
ImmunologyRespiratoryChronic DiseasesNeurologyInflammationNeuroscienceCentral Nervous SystemOncologyBiotechnology

Description

Tiziana Life Sciences Ltd (Tiziana) operates as a biotechnology company. The company specializes in the developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for…

Analysis

Tiziana Life Sciences's 360° View rank of 67 places it above its peer average — better than 67% of its true peers.

It's growing solidly (52) and looks cheap versus peers (85). On safety it is highly leveraged (4), and the market shows favorable sentiment (75). Taken together, its Combined rank of 47 reads as below its peer average.

360° rank · history

1007550250
67
2026

All-time high

87

Mar 2026

All-time low

67

Jun 2026

Average rank

77

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
—
—
—
—
Price/Earnings
69
—
—
—
Price/Book
87
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
85
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Tiziana Life Sciences with its peers
Adocia
PAR:ADOC
63
CountryFrance
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Galapagos
AEX:GLPG
76
CountryBelgium
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
NewAmsterdam Pharma Company
NMQ:NAMS
16
CountryNetherlands
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Heidelberg Pharma
GER:HPHA
32
CountryGermany
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mereo BioPharma Group
NAQ:MREO
51
CountryUK
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
AC Immune
NMQ:ACIU
68
CountrySwitzerland
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →